Breakthrough COVID-19 infections found in 25 per cent healthcare staff in Delhi: StudyMost infections were unrecognised. The Delta- variant thus causes frequent unrecognised breakthrough infections in adequately immunised sub...
Gene linked to pneumonia severity may explain Covid-19 death variations, shows studyThe varied presence of the gene variant in India implies that it is ‘an at risk nation’ with ‘genetic protection’ limited to only certain r...
Delta variant counted for 60% of Delhi's COVID-19 cases in April, says studyThe Delta variant, B.1.617.2, is 50 per cent more transmissible than the Alpha variant, B1.117, first discovered in the UK, say researchers...
COVID-19: Antibodies significantly higher after 7 days of vaccine among those are seropositiveSeropositive people are those who were infected at some point of time. So there are high chances of prevalence of antibodies in them.
Seropositivity for COVID-19 found to be lesser in smokers, vegetarians: CSIR surveyThe study which was piloted by CSIR-Institute of Genomics and Integrative Biology (IGIB), Delhi said of the 10,427 individuals, 1,058 (10.1...
Coronavirus: SpiceHealth, CSIR-IGIB launch genome sequencing lab at Delhi airport"We have started a pilot project with SpiceHealth here at the airport to find out if we can generate the 'sequence' in less than 48 hours a...
Nine more test positive for the COVID-19 mutant strain in DelhiNine more Covid patients have been detected carrying the new and highly infectious strain of novel coronavirus from the UK, taking the tota...
Discovery of a virulent variant of the SARS-CoV-2 should jolt India into speeding up its genome sequencingVariations in gene sequences will keep happening as the virus spreads across the globe, says principal scientific adviser K VijayRaghavan. ...
Feluda test will soon be rolled out to test Covid-19: Harsh VardhanDeveloped by CSIR-IGIB, the paper strip test has been approved by the Drug Controller General of India (DCGI) for a commercial launch.
Tata Group officially ventures into the medical devices with Tata Medical and DiagnosticsOfficially incorporated in July 2020, the company manufactures medical appliances and instruments and appliances for measuring, checking, t...
DCGI approves commercial launch of Tata Group's low cost Covid-19 test 'Feluda'The Tata CRISPR test achieves accuracy levels of traditional RT-PCR tests with quicker turnaround time, less expensive equipment and better...
CSIR submits 53 genome sequences of coronavirus to global body; to share 450 more by May 15CSIR's Institute of Genomics and Integrative Biology (IGIB), Delhi, Centre for Cellular and Molecular Biology (CCMB), Hyderabad and Institu...
'Feluda': Made-in-India paper-based strip for rapid, mass testing for Covid-19A completely indigenous scientific invention, 'Feluda' has been designed for mitigating the ongoing Covid-19 situation and to cater to mass...
CSIR lab, TaTa Sons sign MoU for licensing for COVID-19 knowhowThe license shall include transfer of the knowledge for scaling up the KNOWHOW in the form of a kit that can be deployed for COVID-19 testi...
Genome sequencing: A solution to India's problem of rare genetic diseasesA genome is a person’s complete set of DNA, including all genes with more than 3 billion DNA base pairs. Genome sequencing will lead to pre...
- CSIR authorises private path lab for genetic tests
New Delhi, March 9 (IANS) Hoping to use private pathology labs to reach out to people, the Council of Scientific and Industrial Research (C...
Currency notes host pathogens that can cause diseases: CSIR & IGIB researchThe pathogens on the currency notes can lead to several skin diseases, fungal infections, respiratory disorders and even tuberculosis.